CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, cilt.76, sa.4, ss.535-548, 2020 (SCI-Expanded)
BACKGROUND: Pulmonary arterial hypertension (PAH) is a devastating disease characterized with alterations in pulmonary vasculature yielding increased pulmonary arterial resistance. Emerging evidences suggest important regulatory roles of red blood cells (RBCs) on nitric oxide (NO) bioavailability, mainly by modulating their endothelial nitric oxide synthase (eNOS) enzyme activity.